Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
15. September 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9072
Articles 1 - 20 / 181436
Association of PI-RADS Score with Clinically Significant Prostate Cancer and Histopathological Upgrading in Patients Undergoing Radical Prostatectomy: A Retrospective Single-Centre Study.
J Clin Med
Krzepkowski HA, Z, Wieczorek A, Wal, Kami, D, Syry.
PMID: 42739733 [PubMed]
Renal Cell Carcinoma in the Geriatric Population: Toward a Frailty-Adapted Therapeutic Paradigm.
J Clin Med
Ozsurekci C, Yazar U, Acikgoz Y.
PMID: 42739731 [PubMed - in process]
CT-Based Peritumoral and Perirenal Fat Radiomics in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Grade, Stage, and Adherent Perinephric Fat Prediction.
J Clin Med
Al Mopti A, Alshehri AHD, Alqahtani A.
PMID: 42739725 [PubMed]
Correction: Hausman et al. Urine-Based Machine Learning Assay Detects Prostate Cancer. Diagnostics 2026, 16, 993.
Diagnostics (Basel)
Hausman MS, Ambert K, Nagesetti A, Lim FBH, Swaminathan M, Cardwell RF, Piloto O.
PMID: 42739314 [PubMed]
The Prognostic Role of the Lung Immune Prognostic Index in Neuroendocrine Prostate Cancer: A Multicenter Retrospective Study.
Diagnostics (Basel)
Turan M, Baser MN, Ozkaya Kutluay F, Unlu A, Kutlu O, Cak, Aydin AA, Unal OU, Gokoz Dogu G, Oktay E.
PMID: 42739268 [PubMed]
Post-Treatment NLR and SII Associations with Response and Progression-Free Survival After Neoadjuvant Disitamab Vedotin Plus PD-1 Blockade in Muscle-Invasive Bladder Cancer: A Real-World Cohort Study.
Diagnostics (Basel)
Huang Y, Ji Y, Yang X, Zhao Q, Cao Y, Ma J, You R, Li Y, Yang Y, Du P, Wang S.
PMID: 42739232 [PubMed - in process]
Sarcomatoid Renal Cell Carcinoma: A Clinical Review.
Diagnostics (Basel)
Remiszewski P, Szumera-Cie, Czarnecka AM.
PMID: 42739143 [PubMed]
Cellular Recovery and Therapeutic Rechallenge After Cancer Therapy-Induced Kidney Injury: Mechanistic Insights and Clinical Implications.
Cells
Dotsu Y, Akagi K, Honda N, Matsuo M, Taniguchi H, Takemoto S, Nishino T, Mukae H.
PMID: 42738857 [PubMed - indexed for MEDLINE]
Focused Ultrasound Therapies for Brain, Liver, Prostate, and Breast Cancer Applications: Clinical Evidence and Future Directions.
Cancers (Basel)
Heidar NA, Sheeran D, Nwafor D, Sears OC, Moosa S, Dengel LT, Greene K, Matsumoto AH.
PMID: 42738410 [PubMed]
Circulating Tumor DNA in Bladder Cancer: Current Clinical Evidence and Emerging Multi-Omics Perspectives-A Narrative Review.
Cancers (Basel)
Polito MG, Sisca L, Caruso D, Cosimati A, Ramirez Reinaga CA, Leka E, Santini D, Spinelli GP.
PMID: 42738337 [PubMed]
Cancer Cachexia in Advanced Renal Cell Carcinoma: From Molecular Mechanisms to Prognostic Assessment.
Int J Mol Sci
Cui Y, Cao Y, Lin C, Ma J, Wang S, Du P.
PMID: 42737841 [PubMed - indexed for MEDLINE]
Association Between Biopsy PD-L1 Combined Positive Score and Pathological Upgrading at Radical Prostatectomy in Grade Group 1 Prostate Cancer: A Retrospective Study.
Int J Mol Sci
Pepe L, Zuccalà V, Rizzuto I, Giordano WG, Ballato M, Tralongo P, Ricciardi G, Cianci V, Rossanese M, Iatì G, Parisi S, Pierconti F, Ieni A, Fadda G, Pepe P, Martini M, Fiorentino V.
PMID: 42737775 [PubMed - indexed for MEDLINE]
Repurposing Seleno-L-Methionine as a Pleiotropic Immunomodulatory Agent to Overcome TGF-β1/HIF-Driven Immune Evasion in Clear Cell Renal Cell Carcinoma: Mechanistic Insights and Translational Therapeutic Opportunities.
Int J Mol Sci
Rustum YM.
PMID: 42737754 [PubMed - indexed for MEDLINE]
Intratumoral Human Papillomavirus in Advanced Prostate Cancer: Systematic Review, Meta-Analysis, and Real-World Evidence from the Largest Cohort to Date.
Int J Mol Sci
Brenna D, Puglisi M, Epistolio S, Barizzi J, Pedrani M, Salfi G, Pecoraro G, Turco F, Tortola L, Cozzi S, Zilli T, Leone G, Vogl U, Gillessen S, Frattini M, Pereira Mestre R.
PMID: 42737728 [PubMed - indexed for MEDLINE]
Short-term home-based multimodal prehabilitation for perioperative functional recovery in prefrail and frail older men undergoing radical prostatectomy: a randomized controlled trial.
BMC Geriatr
Wang Z, Wang N, Xu B, Qiu J, Ye X, Lin S, Ouyang L, Feng S, Li N.
PMID: 42736541 [PubMed - indexed for MEDLINE]
The impact of prehabilitation on postoperative outcomes in patients undergoing radical prostatectomy for prostate cancer: a systematic review and meta-analysis.
Support Care Cancer
Wan W, Shen L, Chang Y, Jin X.
PMID: 42736496 [PubMed - indexed for MEDLINE]
Development and validation of a preoperative (18)F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study.
Eur J Nucl Med Mol Imaging
Hu J, Chunyu H, Yang Y, Song Y, Cheng C, Tang H, Chen X, Cheng R, Dai J, Meng H, Zuo C, Zhao J, Li B.
PMID: 42736457 [PubMed - as supplied by publisher]
Treatment Patterns and Outcomes After Recurrence Following Adjuvant Nivolumab for Urothelial Carcinoma: An AGEHA Real-World Study.
Int J Urol
Ogawa I, Narita T, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Tazawa S, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
PMID: 42735287 [PubMed - indexed for MEDLINE]
Distinct Predictors of Early Postoperative and Long-Term Renal Function Decline Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Int J Urol
Matsumoto S, Waseda Y, Kobayashi M, Ishikawa Y, Fukushima H, Yasuda Y, Fukuda S, Tanaka H, Yoshida S, Fujii Y.
PMID: 42735286 [PubMed - indexed for MEDLINE]
The Complementary Roles of the Prostate Health Index and Multiparametric Magnetic Resonance Imaging in Optimizing the Detection of Clinically Significant Prostate Cancer in Patients With Prostate-Specific Antigen Levels Below 10 Ng/mL.
Int J Urol
Sekine Y, Arai G, Kito H, Sugimoto M, Shiota M, Hasumi H, Ito K, Kobori Y, Nakada T, Kato T, Yokomizo A, Ito Y, Suzuki K, Kaji Y.
PMID: 42735240 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 181436
Page 1 of 9072
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy